Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | Furin 1 | 0.0434656 | 0.224689 | 0.288333 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Loa Loa (eye worm) | hypothetical protein | 0.0231121 | 0.0932265 | 0.0917704 |
Echinococcus granulosus | Furin 1 | 0.0434656 | 0.224689 | 0.223444 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Echinococcus multilocularis | 0.128715 | 0.775311 | 1 | |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0434656 | 0.224689 | 0.412742 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Trichomonas vaginalis | proprotein convertase subtilisin/kexin type, putative | 0.0380147 | 0.189482 | 0.348069 |
Echinococcus granulosus | furin | 0.163501 | 1 | 1 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0125974 | 0.025312 | 0.0237469 |
Trichomonas vaginalis | neuroendocrine convertase 2 precursor, putative | 0.0380147 | 0.189482 | 0.348069 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0434656 | 0.224689 | 0.412742 |
Echinococcus granulosus | proprotein convertase subtilisin:kexin type 5 | 0.0929611 | 0.544381 | 0.543649 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0929611 | 0.544381 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0929611 | 0.544381 | 1 |
Echinococcus granulosus | neuroendocrine convertase 2 | 0.114006 | 0.680308 | 0.679795 |
Schistosoma mansoni | tyrosine kinase | 0.0125974 | 0.025312 | 0.025312 |
Brugia malayi | endoprotease bli-4 precursor | 0.163501 | 1 | 1 |
Schistosoma mansoni | neuropeptide receptor | 0.0416649 | 0.213058 | 0.213058 |
Trichomonas vaginalis | hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Schistosoma mansoni | furin-1 (S08 family) | 0.0759911 | 0.434771 | 0.434771 |
Schistosoma mansoni | subfamily S8B unassigned peptidase (S08 family) | 0.163501 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Loa Loa (eye worm) | hypothetical protein | 0.163501 | 1 | 1 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0434656 | 0.224689 | 0.412742 |
Brugia malayi | neuroendocrine convertase 1 precursor | 0.13389 | 0.808742 | 0.808434 |
Loa Loa (eye worm) | endoprotease bli-4 | 0.163501 | 1 | 1 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0125974 | 0.025312 | 0.0237469 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Schistosoma mansoni | hypothetical protein | 0.034787 | 0.168634 | 0.168634 |
Brugia malayi | celfurPC protein | 0.128715 | 0.775311 | 0.77495 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Echinococcus multilocularis | neuropeptide receptor | 0.0416649 | 0.213058 | 0.273301 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0434656 | 0.224689 | 0.412742 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0434656 | 0.224689 | 0.412742 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Giardia lamblia | High cysteine membrane protein Group 2 | 0.0527233 | 0.284485 | 1 |
Schistosoma mansoni | hypothetical protein | 0.00892678 | 0.00160319 | 0.00160319 |
Brugia malayi | proprotein convertase 2 | 0.114006 | 0.680308 | 0.679795 |
Loa Loa (eye worm) | hypothetical protein | 0.073768 | 0.420413 | 0.419482 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0125974 | 0.025312 | 0.0237469 |
Loa Loa (eye worm) | proprotein convertase 2 | 0.0434656 | 0.224689 | 0.223444 |
Echinococcus granulosus | neuropeptide receptor | 0.0416649 | 0.213058 | 0.211795 |
Onchocerca volvulus | 0.00892678 | 0.00160319 | 0.5 | |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0125974 | 0.025312 | 0.0306431 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Schistosoma mansoni | subfamily S8B non-peptidase homologue (S08 family) | 0.0434656 | 0.224689 | 0.224689 |
Echinococcus multilocularis | proprotein convertase subtilisin:kexin type 5 | 0.0929611 | 0.544381 | 0.701528 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034787 | 0.168634 | 0.309772 |
Trichomonas vaginalis | leucine-rich repeat protein, BspA family | 0.034787 | 0.168634 | 0.309772 |
Trichomonas vaginalis | WD repeat domain, putative | 0.00892678 | 0.00160319 | 0.00294498 |
Trichomonas vaginalis | Clan SB, family S8, subtilisin-like serine peptidase | 0.0434656 | 0.224689 | 0.412742 |
Echinococcus multilocularis | neuroendocrine convertase 2 | 0.114006 | 0.680308 | 0.877211 |
Echinococcus multilocularis | G protein coupled receptor 139 | 0.0416649 | 0.213058 | 0.273301 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 2.05 uM | Antimalarial activity against chloroquine-sensetive Plasmodium falciparum 3D7 assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs | ChEMBL. | 21243104 |
EC50 (ADMET) | > 25 uM | Cytotoxicity against human BJ cells after 72 hrs by Cell titer-glo assay | ChEMBL. | 21243104 |
EC50 (ADMET) | > 25 uM | Cytotoxicity against human HEK293 cells after 72 hrs by Cell titer-glo assay | ChEMBL. | 21243104 |
EC50 (ADMET) | > 25 uM | Cytotoxicity against human HepG2 cells after 72 hrs by Cell titer-glo assay | ChEMBL. | 21243104 |
EC50 (ADMET) | > 25 uM | Cytotoxicity against human Raji cells after 72 hrs by Cell titer-glo assay | ChEMBL. | 21243104 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 21243104 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.